IP Library › Assignment 034789/0921
Patent Assignment
Reel/Frame 034789/0921

Assignment of Assignor's Interest

Recorded: 2015-01-22 Pages: 8
Assignors
ZHOU, HAN-JIE
Executed: 2014-12-02
PARLATI, FRANCESCO
Executed: 2015-01-19
WUSTROW, DAVID
Executed: 2014-12-02
Assignee
CLEAVE BIOSCIENCES, INC.
866 MALCOLM ROAD, SUITE 100, BURLINGAME, CALIFORNIA, 94010
Covered Properties (5)
Fused Pyrimidines as Inhibitors of P97 Complex
Fused Pyrimidines and Substituted Quinazolines as Inhibitors of P97
Patent: 9,062,026 →
Application: 13/946,795 →
Publication: US 2014/0024661
Fused Pyrimidines as Inhibitors of P97 Complex
Patent: 9,475,824 →
Application: 14/416,033 →
Publication: US 2015/0239907
Fused Pyrimidines and Substituted Quinazolines as Inhibitors of P97
Application: 61/674,144 →
FUSED PYRIMIDINES AND SUBSTITUTED QUINAZOLINES AS INHIBITORS OF p97
Application: 61/737,666 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 12, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 029994/0318 →
Assignment of Assignor's Interest Mar 12, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 030004/0504 →
Assignment of Assignor's Interest Oct 28, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 031490/0187 →
Assignment of Assignor's Interest Jun 29, 2023
From: CLEAVE THERAPEUTICS, INC.
To: EIKON THERAPEUTICS, INC.
Reel/Frame 064118/0401 →
Assignment of Assignor's Interest Jun 29, 2023
From: CLEAVE THERAPEUTICS, INC.
To: EIKON THERAPEUTICS, INC.
Reel/Frame 064118/0112 →
Change of Name Jul 24, 2023
From: CLEAVE BIOSCIENCES, INC.
To: CLEAVE THERAPEUTICS, INC.
Reel/Frame 064357/0601 →
Change of Name Jul 24, 2023
From: CLEAVE BIOSCIENCES, INC.
To: CLEAVE THERAPEUTICS, INC.
Reel/Frame 064357/0295 →